Human Monoclonal Antibodies as a New Class of Antiinfective Compounds

被引：1

作者：

Burioni, Roberto ^{[1
]}

Lang, Alois B. ^{[2
]}

Capra, J. Donald ^{[3
]}

机构：

[1] Univ Vita Salute San Raffaele, Sch Med, I-20132 Milan, Italy

[2] GeNeuro SA, CH-1228 Geneva, Switzerland

[3] Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA

来源：

CLINICAL & DEVELOPMENTAL IMMUNOLOGY | 2013年

关键词：

STRATEGIES; RESISTANCE; INFLUENZA;

D O I：

10.1155/2013/297120

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页数：2

共 14 条

[11] Mancini N, 2012, NEW ENGL J MED, V367, P871, DOI 10.1056/NEJMc1207116
[12] A potential role for monoclonal antibodies in prophylactic and therapeutic treatment of influenza
Mancini, Nicasio
Solforosi, Laura
Clementi, Nicola
De Marco, Donata
Clementi, Massimo
Burioni, Roberto
[J]. ANTIVIRAL RESEARCH, 2011, 92 (01) : 15 - 26
[13] Teillaud Jean-Luc, 2012, Methods Mol Biol, V911, P3, DOI 10.1007/978-1-61779-968-6_1
[14] Antiviral Resistance and the Future Landscape of Hepatitis C Virus Infection Therapy
Wyles, David L.
[J]. JOURNAL OF INFECTIOUS DISEASES, 2013, 207 : S33 - S39